Show simple item record

dc.contributor.authorGarcía Campelo, María del Rosario 
dc.date.accessioned2017-06-07T07:12:42Z
dc.date.available2017-06-07T07:12:42Z
dc.date.issued2015
dc.identifier.issn0923-7534
dc.identifier.urihttp://hdl.handle.net/20.500.11940/3872
dc.language.isoeng
dc.titleA phase II, multicenter, four-cohort study of oral cMET inhibitor capmatinib (INC280) in patients with EGFR wild-type, advanced NSCLC who have received one or two prior lines of systemic therapy for advanced/metastatic disease
dc.typeArtigoes
dc.authorsophosWolf, J.
dc.authorsophosHochmair, M.
dc.authorsophosKattan, J. G.
dc.authorsophosAng, M. K.
dc.authorsophosGaron, E. B.
dc.authorsophosGroen, H. J. M.
dc.authorsophosHeist, R.
dc.authorsophosOhashi, K.
dc.authorsophosFelip, E.
dc.authorsophosReguart, N.
dc.authorsophosGarcia Campelo, R.
dc.authorsophosSoo, R.
dc.authorsophosPaz-Ares, L.
dc.authorsophosde Marinis, F.
dc.authorsophosSmit, E. F.
dc.authorsophosGiovannini, M.
dc.authorsophosSquires, M.
dc.authorsophosCui, X.
dc.authorsophosZhang, Y.
dc.authorsophosTan, D.
dc.identifier.isi367158700477
dc.identifier.sophos18332
dc.issue.numbersupl 9
dc.journal.titleANNALS OF ONCOLOGY
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña - Complexo Hospitalario Universitario A Coruña::Oncoloxía médica
dc.page.initial146
dc.page.final146
dc.rights.accessRightsopenAccess
dc.typesophosArtículo de Opinión
dc.volume.number26


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record